Do you want to read an article? Please log in or register.
Three-year OCT predictive factors of disease recurrence in eyes with successfully treated myopic choroidal neovascularisation
Macular Diseases
Related content
Macular DiseasesRetinal Diseases
One-year outcomes of anti-vascular endothelial growth factor therapy in peripapillary choroidal neovascularisation
Br J Ophthalmol.
Singh SR, Fung AT, Fraser-Bell S, Lupidi M, Mohan S, Gabrielle PH, Zur D, Iglicki M, M López-Corell P, Gallego-Pinazo R, Farinha C, Lima LH, Mansour AM, Casella AM, Wu L, Silva R, Uwaydat SH, Govindahari V, Arevalo JF, Chhablani J
doi: 10.1136/bjophthalmol-2019-314542.
Macular DiseasesRetinal Diseases
OCT-based biomarkers for predicting treatment response in eyes with centre-involved diabetic macular oedema treated with anti-VEGF injections: a real-life retina clinic-based study
Br J Ophthalmol
Szeto SK, Hui VWK, Tang FY, Yang D, Sun ZH, Mohamed S, Chan CKM, Lai TYY, Cheung C
doi: 10.1136/bjophthalmol-2021-319587
Retinal Diseases
Twenty-four-month outcomes of inflammatory choroidal neovascularisation treated with intravitreal anti-vascular endothelial growth factors: a comparison between two treatment regimens
Br J Ophthalmol.
Invernizzi A, Pichi F, Symes R, Zagora S, Agarwal AK, Nguyen P, Erba S, Xhepa A, De Simone L, Cimino L, Gillies MC, McCluskey PJ
doi: 10.1136/bjophthalmol-2019-315257.
COMMENTED
Macular DiseasesRetinal Diseases
Vascular endothelial growth factor inhibitors for predominantly Caucasian myopic choroidal neovascularization: 2-year treatment outcomes in clinical practice: data from the Fight Retinal Blindness! Registry
★ 1
Recommended and commented by
Dr habil. Gábor Márk Somfai, PhD, Faculty Member
Acta Ophthalmol
Gabrielle PH, Nguyen V, Creuzot-Garcher C, Miguel L, Alforja S, Sararols L, Casaroli-Marano RP, Zarranz-Ventura J, Gillies M, Arnold J, Barthelmes D
doi: 10.1111/aos.14893
Macular Diseases
Outcomes of Anti–Vascular Endothelial Growth Factor Treatment for Choroidal Neovascularization in Fellow Eyes of Previously Treated Patients With Neovascular Age-Related Macular Degeneration
JAMA Ophthalmol.
Stem MS, Moinuddin O, Kline N, Thanos A, Rao P, Williams GA, Hassan TS
Further Publications
High recurrence rate in patients with choroidal hemangioma treated with limited single spot photodynamic therapy during long-term follow-up
Acta Ophthalmol.
Stehouwer M, Schlingemann RO, Verbraak FD
doi: 10.1111/aos.14409.
RECOMMENDED
Retinal Diseases
Rhegmatogenous Retinal Detachment In Children: Clinical Factors Predictive Of Successful Surgical Repair
Ophthalmology.
Smith JM, Ward LT, Townsend JH, Yan J, Hendrick AM, Cribbs BE, Yeh S, Jain N, Hubbard GB 3rd
doi: 10.1016/j.ophtha.2018.11.001.
Hypertension as a risk factor for recurrent subretinal hemorrhage in polypoidal choroidal vasculopathy
Can J Ophthalmol.
Chung YR, Seo EJ, Kim YH, Yang H, Lee K
doi: 10.1016/
Glaucoma and Ocular PressureMacular DiseasesOcular OncologyRetinal Diseases
Factors Associated with Worsening Proliferative Diabetic Retinopathy in Eyes Treated with Panretinal Photocoagulation or Ranibizumab
Ophthalmology.
Bressler SB, Beaulieu WT, Glassman AR, Gross JG, Jampol LM, Melia M, Peters MA, Rauser ME; Diabetic Retinopathy Clinical Research Network.
doi: 10.1016/j.ophtha.2016.12.005.